The Nuclear Receptor Corepressor (NCoR) Controls Thyroid Hormone Sensitivity and the Set Point of the Hypothalamic-Pituitary-Thyroid Axis

被引:70
作者
Astapova, Inna [1 ]
Vella, Kristen R. [1 ]
Ramadoss, Preeti [1 ]
Holtz, Kaila A. [1 ]
Rodwin, Benjamin A. [1 ]
Liao, Xiao-Hui [3 ]
Weiss, Roy E. [3 ]
Rosenberg, Michael A. [2 ]
Rosenzweig, Anthony [2 ]
Hollenberg, Anthony N. [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA
[3] Univ Chicago, Endocrinol Sect, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
BROWN ADIPOSE-TISSUE; ACTION IN-VIVO; HISTONE DEACETYLASE; MICE DEFICIENT; TRANSCRIPTIONAL REPRESSION; ADAPTIVE THERMOGENESIS; TARGETED DISRUPTION; ENERGY-EXPENDITURE; MOLECULAR-BASIS; MESSENGER-RNA;
D O I
10.1210/me.2010-0462
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The role of nuclear receptor corepressor (NCoR) in thyroid hormone (TH) action has been difficult to discern because global deletion of NCoR is embryonic lethal. To circumvent this, we developed mice that globally express a modified NCoR protein (NCoR Delta ID) that cannot be recruited to the thyroid hormone receptor (TR). These mice present with low serum T-4 and T-3 concentrations accompanied by normal TSH levels, suggesting central hypothyroidism. However, they grow normally and have increased energy expenditure and normal or elevated TR-target gene expression across multiple tissues, which is not consistent with hypothyroidism. Although these findings imply an increased peripheral sensitivity to TH, the hypothalamic-pituitary-thyroid axis is not more sensitive to acute changes in TH concentrations but appears to be reset to recognize the reduced TH levels as normal. Furthermore, the thyroid gland itself, although normal in size, has reduced levels of nonthyroglobulin-bound T-4 and T-3 and demonstrates decreased responsiveness to TSH. Thus, the TR-NCoR interaction controls systemic TH sensitivity as well as the set point at all levels of the hypothalamic-pituitary-thyroid axis. These findings suggest that NCoR levels could alter cell-specific TH action that would not be reflected by the serum TSH. (Molecular Endocrinology 25: 212-224, 2011)
引用
收藏
页码:212 / 224
页数:13
相关论文
共 53 条
[1]
Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement [J].
AlAdsani, H ;
Hoffer, LJ ;
Silva, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1118-1125
[2]
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology [J].
Alenghat, Theresa ;
Meyers, Katherine ;
Mullican, Shannon E. ;
Leitner, Kirstin ;
Adeniji-Adele, Adetoun ;
Avila, Jacqueline ;
Bucan, Maja ;
Ahima, Rexford S. ;
Kaestner, Klaus H. ;
Lazar, Mitchell A. .
NATURE, 2008, 456 (7224) :997-U88
[3]
Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [J].
Alland, L ;
Muhle, R ;
Hou, H ;
Potes, J ;
Chin, L ;
SchreiberAgus, N ;
DePinho, RA .
NATURE, 1997, 387 (6628) :49-55
[4]
Effects of maternal levels of thyroid hormone (TH) on the hypothalamus-pituitary-thyroid set point:: Studies in TH receptor β Knockout mice [J].
Alonso, Manuela ;
Goodwin, Charles ;
Liao, XiaoHui ;
Page, David ;
Refetoff, Samuel ;
Weiss, Roy E. .
ENDOCRINOLOGY, 2007, 148 (11) :5305-5312
[5]
In Vivo Interaction of Steroid Receptor Coactivator (SRC)-1 and the Activation Function-2 Domain of the Thyroid Hormone Receptor (TR) β in TRβ E457A Knock-In and SRC-1 Knockout mice [J].
Alonso, Manuela ;
Goodwin, Charles ;
Liao, XiaoHui ;
Ortiga-Carvalho, Tania ;
Machado, Danielle S. ;
Wondisford, Fredric E. ;
Refetoff, Samuel ;
Weiss, Roy E. .
ENDOCRINOLOGY, 2009, 150 (08) :3927-3934
[6]
The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo [J].
Astapovaa, Inna ;
Lee, Larissa J. ;
Morales, Crystal ;
Tauber, Stefanie ;
Bilban, Martin ;
Hollenberg, Anthony N. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (49) :19544-19549
[7]
THE VARIABLE CLINICAL PHENOTYPE IN THYROID-HORMONE RESISTANCE SYNDROME [J].
BECKPECCOZ, P ;
CHATTERJEE, VKK .
THYROID, 1994, 4 (02) :225-232
[8]
TISSUE-SPECIFIC REGULATION OF LIPOGENIC MESSENGER-RNAS BY THYROID-HORMONE [J].
BLENNEMANN, B ;
LEAHY, P ;
KIM, TS ;
FREAKE, HC .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 110 (1-2) :1-8
[9]
BRENT GA, 1994, NEW ENGL J MED, V331, P847
[10]
The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534